Integrum has been granted a registered trademark for OPRA® Implant System in the EU

Mölndal, Sweden – May 15, 2024 — Integrum (publ) (Nasdaq First North Growth Marketing: INTEG B) announces that the European Union Intellectual Property Office, EUIPO, has approved Integrum’s product registration application for the OPRA® Implant System.

Until now, the OPRA® Implant system has been an unregistered mark without legal protection.

As it is granted a registered trademark, Integrum now obtains unitary immaterial protection for the product in the entire territory of the EU.

“We are very pleased to have obtained a registered trademark for OPRA® as it grants us legal protection of the trademark in all EU countries, and we see it as another recognition of our unique offer,” says Rickard Brånemark, CEO of Integrum.